Nel ASA's Q3 2026: A 65% PEM Surge Buried Inside a 63% Revenue Collapse

Nel ASA closed the third quarter of 2026 with NOK 1,078 million in liquid funds and a NOK 1,314 million order backlog — two figures that look reassuring in isolation and say almost nothing about whether the company can make money. The Norwegian hydrogen specialist published those numbers on Thursday alongside a set of results that lay bare the distance between demand for its equipment and the economics of supplying it.

Revenue from customer contracts came in at NOK 112 million, down 63% year on year. Bookings moved in the opposite direction: order intake jumped 339% to NOK 253 million, and the backlog grew 34%. Management credited the PEM business for pulling in the new orders while weak alkaline activity weighed on the overall picture.

Two Businesses, Two Directions

The split within the top line is where the quarter gets interesting. PEM revenue climbed 65% to NOK 89 million. Alkaline revenue fell 91% to NOK 23 million. Those two numbers explain the headline decline far better than any single group-level figure, and they frame the question investors now have to answer: can the growing half of Nel eventually carry the shrinking one?

Not yet, on the evidence. EBITDA was negative NOK 93 million, and the net loss reached NOK 141 million. A thriving PEM line and a loss-making group are plainly not mutually exclusive.

What the Balance Sheet Can and Cannot Tell You

Cash and backlog answer different questions, and conflating them is the easy mistake here. Liquidity measures financial room to manoeuvre on a given date. The order book points to potential future revenue. Neither one demonstrates that Nel has built a self-sustaining operation — the income statement is the document that would show that, and it currently shows the opposite.

Orders booked today also carry no guarantee about the margin at which they will eventually be delivered. A larger backlog improves the outlook; it does not prove a recovery in revenue, and on its own it reveals nothing about the profitability of executing the work.

A US Contract With a 2027 Delivery Date

The most concrete item in the quarter arrived on Tuesday, when Nel Hydrogen US won an order worth roughly USD 12 million from an unnamed global technology company based in the United States. The package covers several containerised MC-series PEM electrolysers plus associated services, with delivery expected in 2027.

That timeline is the point. A signed order and a recognised sale are separated by more than a year of manufacturing and installation, and the contract should not be read as revenue already banked. What it does offer is a fixed horizon against which execution can be judged.

Rheinmetall: An Intent, Not a Business

Also announced Tuesday was a memorandum of understanding with Rheinmetall. The two companies will examine options for decentralised production of renewable fuels, combining Nel's electrolyser technology with Rheinmetall's Giga-PtX concept. It is a feasibility exercise, not realised business, and belongs in the same category as the backlog: perspective rather than proof.

The distinction matters because the two Tuesday announcements are often lumped together. One is a firm order with an expected delivery date. The other is an agreement to study possibilities. Neither substitutes for evidence that Nel can stabilise revenue and narrow its losses.

The Number That Decides the Story

For anyone weighing the bull case, PEM order intake is the place to start: it rose 473% to NOK 245 million, driving the group-wide 339% increase. Should Nel convert those orders into delivered revenue, PEM would carry more weight in the top line and the recovery would depend less on the alkaline business finding its footing.

The bear case writes itself from the same facts. PEM could keep expanding without offsetting the alkaline decline, leaving stronger bookings to sit alongside weak group revenue and further operating losses. That is why the higher order intake is premature as a verdict of turnaround.

Execution is the swing factor. If PEM growth holds and orders turn into revenue, an operating recovery stays plausible. If that momentum fades, or if alkaline weakness continues to dominate, the foundation under the optimistic reading gets thinner. Until the 2027 US delivery lands, PEM revenue remains the yardstick — not the size of the order promise, but what Nel actually makes of it.